August 20, 2014 3:09 PM ET

Life Sciences Tools and Services

Company Overview of BioNano Genomics, Inc.

Company Overview

BioNano Genomics, Inc. offers a platform to analyze the long segments of genomic DNA and other long biomolecules structural variations. The company offers nanoAnalyzer System that allows users to visualize the whole genome capturing long molecules at high resolution; and Irys System, a genome mapping system that empowers genomics researchers to discover structural variation analysis and sequence assemblies. Its platform provides researchers and clinicians with a picture of genomes with insights into how the individual components of genomes are ordered, arranged, and interact with each other. The company works with institutions in life science, translational research, molecular diagnostics, a...

3545 John Hopkins Court

Suite 160

San Diego, CA 92121

United States

Founded in 2003





Key Executives for BioNano Genomics, Inc.

Chief Executive Officer
Age: 46
Founder and Chief Scientific Officer
Chief Financial Officer
Age: 56
Vice President of Corporate Development
Age: 42
Vice President of Global Commercial Operations
Compensation as of Fiscal Year 2014.

BioNano Genomics, Inc. Key Developments

BioNano Genomics, Inc. Appoints Mike Ward to the Senior Executive Management Team and Vice President, Corporate Development

BioNano Genomics, Inc. announced the appointment of Mr. Mike Ward as a member of the senior executive management team and vice president, corporate development. Mr. Ward has more than 20 years of life sciences-dedicated investment banking, venture capital and private equity experience. Before joining BioNano Genomics, Mr. Ward was at Lurie Investment Fund where he was responsible for managing the life sciences venture capital and private equity investments of the Lurie family. Mr. Ward guided senior executive management teams of Lurie's life sciences portfolio companies in conducting business and corporate development, clinical and regulatory strategy, commercialization planning, intellectual property management, M&A and financings. During his tenure, he also served on the boards of a number of life sciences portfolio companies on behalf of Lurie.

BioNano Genomics Appoints Joel Jung as Chief Financial Officer

BioNano Genomics announced the appointment of Mr. Joel Jung as Chief Financial Officer. Mr. Jung has more than 17 years of experience in corporate finance and executive leadership of private and public biotech companies. Before joining BioNano Genomics, Mr. Jung was CFO of Agraquest, Inc.

BioNano Genomics, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-16-2014 12:00 PM

BioNano Genomics, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-16-2014 12:00 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: R. Erik Holmlin, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
HelloLife, LLC United States
Geny Research Group, Inc. United States
Promega Corporation United States
Novus Biologicals, LLC United States
Provid Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Private Placement
June 12, 2014
Private Placement
September 17, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioNano Genomics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at